'I can see clearly now': a new view on the use of IV GP IIb/IIIa inhibitors in acute coronary syndromes

被引：3
作者：
Antman, EM [1 ]
机构：
[1] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
来源：
EUROPEAN HEART JOURNAL | 2002年 / 23卷 / 18期
关键词：
D O I：
10.1053/euhj.2001.3270
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1408 / 1411
页数：4
相关论文
共 20 条
[1]   Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction - TIMI 11B-ESSENCE meta-analysis [J].
Antman, EM ;
Cohen, M ;
Radley, D ;
McCabe, C ;
Rush, J ;
Premmereur, J ;
Braunwald, E .
CIRCULATION, 1999, 100 (15) :1602-1608
[2]   Troponin measurements in ischemic heart disease: More than just a black and white picture [J].
Antman, EM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (04) :987-990
[3]  
Bazzino O, 1998, NEW ENGL J MED, V338, P1498
[4]  
Bazzino O, 1998, NEW ENGL J MED, V338, P1488
[5]   Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes -: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention [J].
Boersma, E ;
Akkerhuis, KM ;
Théroux, P ;
Califf, RM ;
Topol, EJ ;
Simoons, ML .
CIRCULATION, 1999, 100 (20) :2045-2048
[6]   Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes:: a meta-analysis of all major randomised clinical trials [J].
Boersma, E ;
Harrington, RA ;
Moliterno, DJ ;
White, H ;
Théroux, P ;
Van de Werf, F ;
de Torbal, A ;
Armstrong, PW ;
Wallentin, LC ;
Wilcox, RG ;
Simes, J ;
Califf, RM ;
Topol, EJ ;
Simoons, ML .
LANCET, 2002, 359 (9302) :189-198
[7]  
BRAUNWALD E, 2002, ACC AHA GUIDELINE UP
[8]   USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].
CALIFF, RM ;
SHADOFF, N ;
VALETT, N ;
BATES, E ;
GALEANA, A ;
KNOPF, W ;
SHAFTEL, J ;
BENDER, MJ ;
AVERSANO, T ;
RAQUENO, J ;
GURBEL, P ;
COWFER, J ;
COHEN, M ;
CROSS, P ;
BITTL, J ;
EDDINGS, K ;
TAYLOR, M ;
DEROSA, K ;
HATTEL, L ;
COOPER, L ;
ESHELMAN, B ;
FINTEL, D ;
NIEMYSKI, P ;
KLEIN, L ;
KENNEDY, H ;
THORNTON, T ;
KEREIAKES, D ;
MARTIN, L ;
ANDERSON, L ;
HIGBY, N ;
ELLIS, S ;
BREZINA, K ;
GEORGE, B ;
CHAPEKIS, A ;
SMITH, D ;
ANWAR, A ;
GERBER, TL ;
PRITCHARD, GL ;
MYLER, R ;
SHAW, R ;
MURPHY, M ;
WARD, K ;
MADIGAN, NP ;
BLANKENSHIP, J ;
HALBERT, M ;
FLANAGAN, C ;
TANNENBAUM, M ;
POLICH, M ;
STEVENSON, C ;
TCHENG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961
[9]   Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. [J].
Cannon, CP ;
Weintraub, WS ;
Demopoulos, LA ;
Vicari, R ;
Frey, MJ ;
Lakkis, N ;
Neumann, FJ ;
Robertson, DH ;
DeLucca, PT ;
DiBattiste, PM ;
Gibson, CM ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) :1879-1887
[10]  
Hanrath P, 1997, CIRCULATION, V96, P1445
12